KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Short term Debt (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Short term Debt for 17 consecutive years, with $504.0 million as the latest value for Q4 2025.

  • Quarterly Short term Debt fell 16.28% to $504.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $504.0 million through Dec 2025, down 16.28% year-over-year, with the annual reading at $504.0 million for FY2025, 16.28% down from the prior year.
  • Short term Debt hit $504.0 million in Q4 2025 for Quest Diagnostics, roughly flat from $504.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $906.0 million in Q1 2024 to a low of $1.0 million in Q3 2021.
  • Historically, Short term Debt has averaged $268.6 million across 5 years, with a median of $152.5 million in 2021.
  • Biggest five-year swings in Short term Debt: soared 45200.0% in 2024 and later tumbled 99.89% in 2025.
  • Year by year, Short term Debt stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then surged by 15050.0% to $303.0 million in 2023, then skyrocketed by 98.68% to $602.0 million in 2024, then dropped by 16.28% to $504.0 million in 2025.
  • Business Quant data shows Short term Debt for DGX at $504.0 million in Q4 2025, $504.0 million in Q3 2025, and $504.0 million in Q2 2025.